glp-1 medicamentos nombre comercial GLP-1: ¿qué son y para qué sirven?, en diabetes y control de peso Uno de cada cuatro personas

and scholarships from Astellas, Daiichi Sankyo, Takeda, Mitsubishi Tanabe, Boehringer Ingelheim, Bristol-Myers Squibb, and Teijin

Acknowledgements Figures are created with BioRender.com

These trials are mostly based on composite reductions in MACEs (similar to the original ELIXA trial endpoint)

An interruption of just six months before resuming treatment still reduced the cardiovascular benefit, leading to a 4% to 8% increase in risk, compared to continuous use

Comparison of GLP-1 Medication Types Different GLP-1 medications vary in their cardiovascular benefits and safety considerations, making it essential to choose the right one for each patient